Significance of low peripheral blood CD34+ cell numbers prior to leukapheresis: What should the threshold required for apheresis be?

Bone Marrow Transplantation

Volumn 42, Issue 7, 2008, Pages 439-442

  Gidron, A ^a   Singh, V ^a   Egan, K ^a   Mehta, J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; AUTOTRANSPLANTATION; BLOOD VOLUME; BODY WEIGHT; CD34 SELECTION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FLOW CYTOMETRY; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; LEUKAPHERESIS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ANTIGENS, CD34; BLOOD COMPONENT REMOVAL; CELL COUNT; CELL SEPARATION; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; RETROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 54349098962     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.187     Document Type: Article

References (11)

1. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961-3969.
2. Ali MY, Oyama Y, Monreal J, Winter JN, Tallman MS, Williams SF et al. Ideal or actual body weight to calculate CD34+ cell doses for autologous hematopoietic stem cell transplantation? Bone Marrow Transplant 2003; 31: 861-864.
3. Elliott C, Samson DM, Armitage S, Lyttelton MP, McGuigan D, Hargreaves R et al. When to harvest peripheral-blood stem cells after mobilization therapy: Prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. J Clin Oncol 1996; 14: 970-973.
4. Mehta J, Oyama Y, Winter J, Williams S, Tallman M, Singhal S et al. CD34+ cell collection efficiency does not correlate with the pre-leukapheresis hematocrit. Bone Marrow Transplant 2001; 28 597-601.
5. Gidron A, Verma A, Doyle M, Evens A, Gordon L, Singhal S et al. Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies? Bone Marrow Transplant 2005; 35: 243-246.
6. Pérez-Simón JA, Caballero MD, Corral M, Nieto MJ, Orfao A, Vazquez L et al. Minimal number of circulating CD34+ cells to ensure successful leukapheresis and engraftment in autologous peripheral blood progenitor cell transplantation. Transfusion 1998; 38: 385-391.
7. Basquiera AL, Abichain P, Damonte JC, Ricchi B, Sturich AG, Palazzo ED et al. The number of CD34+ cells in peripheral blood as a predictor of the CD34+ yield in patients going to autologous stem cell transplantation. J Clin Apher 2006; 21: 92-95.
8. 3 as a surrogate marker to initiate efficient autologous blood stem cell collection. J Clin Apher 2007; 22 277-282.
9. Rick O, Beyer J, Kingreen D, Kühl JS, Zingsem J, Huhn D et al. Successful autologous bone marrow rescue in patients who failed peripheral blood stem cell mobilization. Ann Hematol 2000; 79 681-686.
10. Lemoli RM, de Vivo A, DamianiD, Isidori A, Tani M, Bonini A et al. Autologous transplantation of granulocyte colony-stimulating factor-primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization. Blood 2003; 102: 1595-1600.
11. Goterris R, Hernández-Boluda JC, Teruel A, Gómez C, Lis MJ, Terol MJ et al. Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers. Bone Marrow Transplant 2005; 36: 847-853.